Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT02881242 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02881242
Sponsor: Jonsson Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2018-01-30
Primary completion: 2024-01-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.